An exploratory clinical trial to evaluate the safety and efficacy of combination therapy of REGROTH® and Cytrans® granules for severe periodontitis with intrabony defects

INTRODUCTION: Currently, flap operation (FOP) using REGROTH® (0.3% basic fibroblast growth factor [FGF-2]) is the standard treatment for periodontal regenerative therapy in Japan. However, the periodontal tissue regenerative effect with REGROTH® monotherapy is inadequate for severe alveolar bone def...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitamura, Masahiro, Yamashita, Motozo, Miki, Koji, Ikegami, Kuniko, Takedachi, Masahide, Kashiwagi, Yoichiro, Nozaki, Takenori, Yamanaka, Katsuyuki, Masuda, Hijiri, Ishihara, Yoko, Murakami, Shinya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234541/
https://www.ncbi.nlm.nih.gov/pubmed/35785043
http://dx.doi.org/10.1016/j.reth.2022.06.001

Ejemplares similares

Ejemplares similares